Pharmacy alerts
-
Crescent Pharma Limited, Ramipril 2.5 mg Capsules, recall
Class 2 medicines recall: The MHRA have published a Class 2 medicines recall for ramipril 2.5mg capsules.
-
Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis defect
Class 4 medicines defect notification: The MHRA has published a Class 4 medicines defect notification for Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis.
-
Finasteride and Dutasteride – updated safety warnings
The MHRA has reviewed evidence for the risk of psychiatric side effects and sexual dysfunction.
-
Milpharm Limited, loperamide hydrochloride 2 mg orodispersible tablets defect notification
Class 4 medicines defect notification: The MHRA has issued a Class 4 defect notification for loperamide hydrochloride 2 mg orodispersible tablets
-
Nasal decongestant sprays and drops containing xylometazoline hydrochloride/ oxymetazoline hydrochloride
Drug Safety Update: The MHRA has published a drug safety update on nasal decongestant sprays and drops containing xylometazoline hydrochloride/oxymetazoline hydrochloride.
-
Amarox Limited, Sertraline 100mg film-coated tablets recall
Class 2 medicines recall: The MHRA has published a Class 2 medicines recall for Sertraline 100mg film-coated tablets.